Literature DB >> 7663510

The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains.

J Hughes1, C J Ward, B Peral, R Aspinwall, K Clark, J L San Millán, V Gamble, P C Harris.   

Abstract

Characterization of the polycystic kidney disease 1 (PKD1) gene has been complicated by genomic rearrangements on chromosome 16. We have used an exon linking strategy, taking RNA from a cell line containing PKD1 but not the duplicate loci, to clone a cDNA contig of the entire transcript. The transcript consists of 14,148 bp (including a correction to the previously described C terminus), distributed among 46 exons spanning 52 kb. The predicted PKD1 protein, polycystin, is a glycoprotein with multiple transmembrane domains and a cytoplasmic C-tail. The N-terminal extracellular region of over 2,500 aa contains leucine-rich repeats, a C-type lectin, 16 immunoglobulin-like repeats and four type III fibronectin-related domains. Our results indicate that polycystin is an integral membrane protein involved in cell-cell/matrix interactions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7663510     DOI: 10.1038/ng0695-151

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  277 in total

1.  Mutation detection of PKD1 identifies a novel mutation common to three families with aneurysms and/or very-early-onset disease.

Authors:  T Watnick; B Phakdeekitcharoen; A Johnson; M Gandolph; M Wang; G Briefel; K W Klinger; W Kimberling; P Gabow; G G Germino
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

2.  Specific association of the gene product of PKD2 with the TRPC1 channel.

Authors:  L Tsiokas; T Arnould; C Zhu; E Kim; G Walz; V P Sukhatme
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

3.  Structural similarity to link sequence space: new potential superfamilies and implications for structural genomics.

Authors:  Patrick Aloy; Baldomero Oliva; Enrique Querol; Francesc X Aviles; Robert B Russell
Journal:  Protein Sci       Date:  2002-05       Impact factor: 6.725

4.  Role of genetic modifiers in an orthologous rat model of ARPKD.

Authors:  Caitlin C O'Meara; Matthew Hoffman; William E Sweeney; Shirng-Wern Tsaih; Bing Xiao; Howard J Jacob; Ellis D Avner; Carol Moreno
Journal:  Physiol Genomics       Date:  2012-06-05       Impact factor: 3.107

5.  A family with a milder form of adult dominant polycystic kidney disease not linked to the PKD1 (16p) or PKD2 (4q) genes.

Authors:  M Ariza; V Alvarez; R Marín; S Aguado; C López-Larrea; J Alvarez; M J Menéndez; E Coto
Journal:  J Med Genet       Date:  1997-07       Impact factor: 6.318

6.  Altered trafficking and stability of polycystins underlie polycystic kidney disease.

Authors:  Yiqiang Cai; Sorin V Fedeles; Ke Dong; Georgia Anyatonwu; Tamehito Onoe; Michihiro Mitobe; Jian-Dong Gao; Dayne Okuhara; Xin Tian; Anna-Rachel Gallagher; Zhangui Tang; Xiaoli Xie; Maria D Lalioti; Ann-Hwee Lee; Barbara E Ehrlich; Stefan Somlo
Journal:  J Clin Invest       Date:  2014-11-03       Impact factor: 14.808

7.  Native polycystin 2 functions as a plasma membrane Ca2+-permeable cation channel in renal epithelia.

Authors:  Ying Luo; Peter M Vassilev; Xiaogang Li; Yoshifumi Kawanabe; Jing Zhou
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

Review 8.  A cut above (and below): Protein cleavage in the regulation of polycystin trafficking and signaling.

Authors:  Valeria Padovano; Kavita Mistry; David Merrick; Nikolay Gresko; Michael J Caplan
Journal:  Cell Signal       Date:  2020-04-10       Impact factor: 4.315

9.  Evaluating the clinical utility of a molecular genetic test for polycystic kidney disease.

Authors:  Miguel A Garcia-Gonzalez; Jeffrey G Jones; Susan K Allen; Christopher M Palatucci; Sat D Batish; William K Seltzer; Zheng Lan; Erica Allen; Feng Qian; Xose M Lens; York Pei; Gregory G Germino; Terry J Watnick
Journal:  Mol Genet Metab       Date:  2007-06-18       Impact factor: 4.797

10.  HDAC6 is overexpressed in cystic cholangiocytes and its inhibition reduces cystogenesis.

Authors:  Sergio A Gradilone; Stefan Habringer; Tatyana V Masyuk; Brynn N Howard; Anatoliy I Masyuk; Nicholas F Larusso
Journal:  Am J Pathol       Date:  2014-01-13       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.